Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 2014

Thyroid Autoimmune Adverse Events in Patients Treated with Alemtuzumab for Relapsing-remitting Multiple Sclerosis: Four-year Follow-up of the CARE-MS Studies (P2.199)

OBJECTIVE: Summarize incidence and timing of thyroid autoimmune adverse events (AEs) in the ongoing CARE-MS extension study (as of July 15, 2013). BACKGROUND...

13 citationsDOI: https://doi.org/10.1212/wnl.82.10_supplement.p2.199
Thyroid Autoimmune Adverse Events in Patients Treated with Alemtuzumab for Relapsing-remitting Multiple Sclerosis: Four-year Follow-up of the CARE-MS Studies (P2.199)